Andreas Chrysostomou

Managing Director, Valuation Services Global Healthcare & Life Sciences Industry Leader at Kroll

Speaker

Andreas with more than 30 years in the valuation industry has developed expertise in all areas of business valuations, including the determining of business enterprise value, valuation intangible assets for corporate and individual clients with particular focus on pharmaceutical, biotechnology, life sciences and the specialty chemicals industries. He also has extensive experience in servicing Healthcare Systems and Physician practices, Healthcare and Pharma services sectors, as well as the telecom, consumer product and manufacturing and financial services industries. Andreas’ clients includes some of the largest pharmaceutical, generic biotechnology and life sciences companies, as well as healthcare systems in the United States, Europe and Asia. Andreas has been involved in numerous multi-billion dollar companies and transactions within his industry focus but also worked with numerous mid-size and start-up companies.